Details for 2017709189

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR VERWENDUNG VON FXR-AGONISTEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017709189

EP Publication Number

3419625

E-Number

1378774

Language

PCT Number

IB17050963

Publication Date

02.01.2019 A

07.04.2021 B1

Registration Date

07.04.2021

AT Publication Date

15.04.2021

Application Date

20.02.2017

Registration Number

Priorities

22.02.2016

201662298121 P

12.12.2016

201662420661 P

IPC

A61K 31/46 20060101AFI20170901BHEP

Maximum Duration of Protection

20.02.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße1010 WienAT

Inventor

LAFFITTE, Bryanc/o Novartis Institute for Functional Genomics Inc. dba The Genomics Institute of the Novartis Research Foundation (GNF) 10675 John Jay Hopkins Drive San Diego, California 92121US

BADMAN, Michaelc/o Novartis Institutes for Biomedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

CHEN, Jinc/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

LINDGREN, Samc/o Novartis Pharma AG Postfach 4002 BaselCH